Evaluation of CD146 as Target for Radioimmunotherapy against Osteosarcoma

BACKGROUND: Osteosarcoma is a rare form of cancer but with a substantial need for new active drugs. There is a particular need for targeted therapies to combat metastatic disease. One possible approach is to use an antibody drug conjugate or an antibody radionuclide conjugate to target the osteosarc...

Descripción completa

Detalles Bibliográficos
Autores principales: Westrøm, Sara, Bønsdorff, Tina B., Abbas, Nasir, Bruland, Øyvind S., Jonasdottir, Thora J., Mælandsmo, Gunhild M., Larsen, Roy H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5077112/
https://www.ncbi.nlm.nih.gov/pubmed/27776176
http://dx.doi.org/10.1371/journal.pone.0165382

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5077112/
https://www.ncbi.nlm.nih.gov/pubmed/27776176
http://dx.doi.org/10.1371/journal.pone.0165382

Ejemplares similares